Duration of Chest Tube Suction in Traumatic Pneumothorax (NCT04986527) | Clinical Trial Compass
WithdrawnNot Applicable
Duration of Chest Tube Suction in Traumatic Pneumothorax
Stopped: study does not have funding
United States0Started 2021-10-01
Plain-language summary
The purpose of this pilot study is to determine whether chest tube suction duration, 24 hours vs 48 hours, prior to water seal affects outcome and length of stay after placement for traumatic pneumothorax.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Trauma service consult/patient
* Traumatic pneumothorax with chest tube placed within 0-24 hours of presentation and confirmation of adequate position
* Age \>18
* Blunt or penetrating mechanism
* Chest tubes sizes 14 to 32Fr
* Chest tubes placed by residents on the trauma surgery service supervised by attending trauma surgeons or placed by the attending surgeon themselves
* Presence of single chest tube in one or both pleural cavities (single unilateral or bilateral tubes)
* Subjects with decision making capacity (DMC) who are able to provide written consent. DMC will be determined by the consenting physician through a teach back mechanism. Subjects must demonstrate understanding of the situation, appreciation of the consequences of their decision, reasoning of their thought process, and be able to communicate their wishes.
Exclusion Criteria:
* Age \<18
* Pregnant patients
* Prisoners
* Mechanically ventilated in ICU for more than 24 hours while chest tube in place
* Chest tubes placed as part of, or present during, a thoracic operation
* History of surgery involving pleural cavity ipsilateral to chest tube
* Subjects with more than one chest tube on the ipsilateral side at any time prior to study chest tube removal
* Subjects with chylothorax or empyema
* Subjects with chest tubes that are withdrawn or removed unintentionally
* Subjects with known or suspected bronchial injury
* Subjects with bullous emphysema.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.